Hyperprolactinemia
|
0.600 |
Biomarker
|
disease |
CTD_human |
Development of anti-PRL (prolactin) autoantibodies by homologous PRL in rats: a model for macroprolactinemia.
|
17303669 |
2007 |
Prolactinoma
|
0.600 |
Biomarker
|
disease |
CTD_human |
[Disappearance of the radiographic image of a macroprolactinoma after treatment with bromocriptine].
|
9617019 |
1998 |
Prolactinoma
|
0.600 |
Biomarker
|
disease |
CTD_human |
[A case of prolactinoma presenting with CSF rhinorrhea and CSF otorrhea during bromocriptine therapy].
|
1407345 |
1992 |
Hyperprolactinemia
|
0.600 |
Biomarker
|
disease |
CTD_human |
Effect of chronic hyperprolactinemia induced by sulpiride on plasma dehydroepiandrosterone (DHA) in normal men.
|
2948424 |
1987 |
Hyperprolactinemia
|
0.600 |
Biomarker
|
disease |
CTD_human |
Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states.
|
2880862 |
1987 |
Prolactinoma
|
0.600 |
Biomarker
|
disease |
CTD_human |
By immunoelectron microscopy, in the estrogen induced prolactinoma, PRL was localized in well developed lamellar or whorling rough endoplasmic reticulum (RER) and Golgi saccules.
|
3776530 |
1986 |
Hyperprolactinemia
|
0.600 |
Biomarker
|
disease |
CTD_human |
Sulpiride-induced hyperprolactinemia and impotence in male psychiatric outpatients.
|
4001434 |
1985 |
Prolactinoma
|
0.600 |
Biomarker
|
disease |
CTD_human |
Pituitary apoplexy following chlorpromazine stimulation.
|
718334 |
1978 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
PSYGENET |
The results may suggest a possible abnormality of the functional -1149 G/T polymorphism of the prolactin gene in schizophrenia, especially in male patients, similar to that found in autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis.
|
22094377 |
2012 |
Lupus Erythematosus, Systemic
|
0.400 |
Biomarker
|
disease |
CTD_human |
After metoclopramide, secretion and production of PRL increased only in PBMNC from control women and not in those from SLE patients.
|
14870917 |
2004 |
Adenoma
|
0.400 |
Biomarker
|
group |
CTD_human |
SUNCT syndrome in two patients with prolactinomas and bromocriptine-induced attacks.
|
12058109 |
2002 |
Macroprolactinoma
|
0.400 |
Biomarker
|
disease |
CTD_human |
[Disappearance of the radiographic image of a macroprolactinoma after treatment with bromocriptine].
|
9617019 |
1998 |
Macroprolactinoma
|
0.400 |
Biomarker
|
disease |
CTD_human |
[A case of prolactinoma presenting with CSF rhinorrhea and CSF otorrhea during bromocriptine therapy].
|
1407345 |
1992 |
Adenoma
|
0.400 |
Biomarker
|
group |
CTD_human |
[Morphological changes in prolactinoma induced by bromocriptine treatment].
|
2274009 |
1991 |
Pituitary Adenoma
|
0.400 |
Biomarker
|
disease |
CTD_human |
[Morphological changes in prolactinoma induced by bromocriptine treatment].
|
2274009 |
1991 |
Pituitary Adenoma
|
0.400 |
Therapeutic
|
disease |
CTD_human |
[Morphological changes in prolactinoma induced by bromocriptine treatment].
|
2274009 |
1991 |
Pituitary Adenoma
|
0.400 |
Biomarker
|
disease |
CTD_human |
Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study.
|
3498743 |
1987 |
Pituitary Adenoma
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study.
|
3498743 |
1987 |
Macroprolactinoma
|
0.400 |
Biomarker
|
disease |
CTD_human |
Ultrastructural localization of prolactin in estrogen-induced prolactinoma of the rat pituitary. Experimental models for the human prolactinomas and the effects of bromocriptine.
|
3776530 |
1986 |
Pituitary Adenoma
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Synergism of diethylstilbestrol and other carcinogens in concurrent development of hepatic, mammary, and pituitary tumors in castrated male rats.
|
6156259 |
1980 |
Pituitary Adenoma
|
0.400 |
Biomarker
|
disease |
CTD_human |
Synergism of diethylstilbestrol and other carcinogens in concurrent development of hepatic, mammary, and pituitary tumors in castrated male rats.
|
6156259 |
1980 |
Macroprolactinoma
|
0.400 |
Biomarker
|
disease |
CTD_human |
Pituitary apoplexy following chlorpromazine stimulation.
|
718334 |
1978 |
Endometriosis
|
0.370 |
Biomarker
|
disease |
CTD_human |
Higher serum PRL levels were observed in patients with endometriosis at baseline and after 15 and 30 min of TRH administration.
|
11925390 |
2002 |
Heart failure
|
0.350 |
Biomarker
|
disease |
CTD_human |
Recovery from peripartum cardiomyopathy after treatment with bromocriptine.
|
18926768 |
2008 |
Congestive heart failure
|
0.350 |
Biomarker
|
disease |
CTD_human |
Recovery from peripartum cardiomyopathy after treatment with bromocriptine.
|
18926768 |
2008 |